Medicenna Therapeutics Corp (MDNA : TSX)
Common Stock
$0.43
CAD
+0.01 (2.38%)
Last updated: 2026-10-27
Follow MDNA
MDNA
Medicenna Therapeutics Corp
WealthAwesomePerformance
1 Day
+2.38%
1 Week
+10.26%
1 Month
+6.17%
YTD
-57.00%
Key Statistics
Market Cap
$39.69M
52W High
$1.78
52W Low
$0.34
P/E Ratio
-
50 Day MA
$0.43
200 Day MA
$0.56
Beta
2.10
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/27/2026 | $0.42 | $0.45 | $0.42 | $0.43 | $0.43 | 16,606 |
| 10/26/2026 | $0.42 | $0.43 | $0.42 | $0.42 | $0.42 | 42,680 |
| 10/23/2026 | $0.42 | $0.45 | $0.42 | $0.42 | $0.42 | 33,215 |
| 10/22/2026 | $0.41 | $0.42 | $0.41 | $0.42 | $0.42 | 7,581 |
| 10/21/2026 | $0.39 | $0.42 | $0.39 | $0.41 | $0.41 | 89,293 |
| 10/20/2026 | $0.39 | $0.40 | $0.39 | $0.39 | $0.39 | 53,508 |
| 10/19/2026 | $0.45 | $0.45 | $0.39 | $0.41 | $0.41 | 96,838 |
| 10/16/2026 | $0.44 | $0.45 | $0.44 | $0.45 | $0.45 | 20,028 |
| 10/15/2026 | $0.45 | $0.45 | $0.44 | $0.44 | $0.44 | 10,650 |
| 10/14/2026 | $0.45 | $0.45 | $0.42 | $0.44 | $0.44 | 8,815 |
Analyst Price Targets
Based on analyst covering MDNA · as of Sep 17, 2026
Wall Street analysts forecast MDNA stock price to rise 644.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.20
+644.2% Upside
Current Price
C$0.43
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDNA's historical volatility
30-Day Vol
53.4%
Annualized
90-Day Vol
53.0%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.51
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.46 | C$0.38 – C$0.55 |
| 60 trading days | C$0.48 | C$0.37 – C$0.63 |
| 90 trading days | C$0.51 | C$0.37 – C$0.71 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Medicenna Therapeutics Corp
Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, an interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; and MDNA113, a tumor-targeting and activatable bifunctional anti-PD-1-IL-2 superkine for cancer. In addition, its preclinical products are MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases, including transplant rejection; and MDNA413, an IL-4/IL-13 antagonist to inflammatory, asthma, and atopic dermatitis, as well as other allergic diseases. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-22.36M
- Profit Margin
- 0.00%
- ROE (TTM)
- -227.57%
- EPS (Diluted)
- -0.22
- Book Value
- 0.02
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About MDNA
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| SLT | Saltire Capital Ltd. | $2.50 | +25.00% |
| BNG | Bengal Energy Ltd | $0.03 | +20.00% |
| ARN | Asarian Energy Limited | $0.43 | +17.81% |
| EGLX | Enthusiast Gaming Holdings Inc | $0.04 | +16.67% |
| XNDU | Xanadu Quantum Technologies Limited | $4.13 | +15.36% |
| SLR | Solitario Exploration & Royalty Corp | $0.74 | +12.12% |
| CLS | Celestica Inc. | $388.33 | +11.92% |
| LAM | Laramide Resources Ltd. | $0.48 | +11.63% |
MDNA.TO news timeline
15 articles covering MDNA.TO, most recent first
LatestWhy Medicenna Therapeutics Corp stock is rising today
October 2026
September 2026
- What's Going On With Medicenna Therapeutics Corp Stock Thursday?
- Why Medicenna Therapeutics Corp stock fell yesterday
- What's Going On With Medicenna Therapeutics Corp Stock Wednesday?
- Why Medicenna Therapeutics Corp stock fell yesterday
- Why Medicenna Therapeutics Corp stock plummeted yesterday
- What's Going On With Medicenna Therapeutics Corp Stock Wednesday?